Cepheid
@CepheidNews
Followers
11K
Following
136
Media
563
Statuses
967
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility.
Sunnyvale, CA
Joined August 2010
A groundbreaking Yale-led initiative is transforming hepatitis C care by delivering same-day diagnosis and treatment directly in the community—no clinic visit required. Cepheid stands by breaking down barriers to HCV care. Read the full story: https://t.co/l8tpcsinDP
medicine.yale.edu
A new initiative led by Yale’s Rick Altice, MD, is removing barriers to hepatitis C virus (HCV) care by providing same-day diagnosis and treatment in the
0
1
1
Congratulations to the Broad Institute on receiving an outstanding award from the MacArthur Foundation. Honored to have partnered with Dr. Sabeti to deliver mpox tests during the recent outbreak. https://t.co/F6uFijbI7X
macfound.org
0
0
0
Cepheid is a proud sponsor at the #Colab2025. Don’t miss our expert-led symposium as Mark Fisher presents on the community-driven approach to STI diagnostics, focusing on how peer-led initiatives are expanding #POC testing to populations. https://t.co/eD9RxkIzBl
0
0
0
Explore Cepheid’s advanced #MolecularDiagnostics at ECC Conference 2025 — fast, accurate #PCR solutions. Visit us at Booth #11 from 15–17 September to discuss how #GeneXpert can improve patient management in urgent care settings. Learn more: https://t.co/mZ11H2gj9Y
1
0
0
Longer hospital stays, reduced patient functionality, and lost productivity all add pressure to our healthcare system. Dr. Paul Griffin, Director of ID at Mater Health Services on the urgency & cost-effectiveness of timely #moleculardiagnostics #Respiratory using #PCR
0
0
0
Cepheid is pleased to announce Health Canada Licence for Xpert® HCV VL Fingerstick. Read more! https://t.co/Frd1euoaCz
cepheid.mediaroom.com
Detection and quantitation of Hepatitis C virus (HCV) in about an hour SUNNYVALE, Calif. , Aug. 19, 2025 /PRNewswire/ -- Cepheid today announced that Health Canada has issued Cepheid a medical...
0
0
1
Join us at the 46th Annual #NZSHS 2025 Conference! Stop by Booth #07 on 16 August to explore #Cepheid advanced #MolecularDiagnostics, featuring fast, accurate solutions across #SexualHealth #WomensHealth #Virology #PCR #GeneXpert #POC #PointofCare
https://t.co/1A4KpejbD4
forumpoint2.eventsair.com
0
0
1
Dr. Paul Griffin, Director of Infectious Diseases at Mater Health Services in Brisbane, has voiced significant concerns about the 2025 respiratory season in Australia, particularly regarding the surge in #influenza, #RSV, and #COVID-19 cases. https://t.co/HXpNlvUKMP
0
0
1
Hepatitis C is a silent epidemic in the U.S., but this small clinic is proving it doesn't have to be
cbsnews.com
Here's how a small clinic in Buffalo, New York, could inspire a national plan to eliminate hepatitis C.
8
6
15
🦠 Antimicrobial and Diagnostic Stewardship: What to know and why it matters for your hospital or healthcare system. 📑 Access the Frost & Sullivan Visual Whitepaper now: https://t.co/Zc0mPvZjVl
0
0
0
Be part of the conversation at our Cepheid’s upcoming Symposium! Don’t miss this opportunity to engage with leaders in the field on Thursday, 19th June at #POC25
https://t.co/FEEGzOEtlR
#PointOfCareTesting #Conference #POC
0
1
0
At APIC 2025, learn how #PCR testing from Cepheid can help support antimicrobial stewardship efforts with speed, accuracy, and flexibility. #PCR #antimicrobialstewardship #infectiousdiseases
https://t.co/Be8aCyldpD
0
0
1
At APIC 2025, learn how #PCR testing from Cepheid can help support antimicrobial stewardship efforts with speed, accuracy, and flexibility. #PCR #antimicrobialstewardship #infectiousdiseases
https://t.co/NfNBO3freL
0
0
0
🚨 Big news in the fight to #EndHepC in the United States! Sens. Cassidy (R-LA) & Van Hollen (D-MD) just introduced the Cure Hepatitis C Act—expanding testing & curative treatment to save 24K lives and $18B over 10 years. #PublicHealth #EndHepatitisC
1
3
5
💡 In-house #PCR testing: Clinical leaders explore the ripple effects on patient care, financial health, and the workforce. 📑 Read more: https://t.co/dX6ABh5h8s
0
0
0
📰 Breaking News! Cepheid Receives Health Canada Licence for Xpert® HIV-1 Viral Load XC Next-Generation Molecular Test for Monitoring Viral Load and HIV-1 Infection. #MolecularDiagnostics #HIV 📢 Read more: https://t.co/owt2Y5dJ3T
0
0
0
🏥 Discover how decentralized diagnostics in the U.K. can positively transform healthcare delivery through improved patient outcomes, alleviate pressure on hospital services and contribute to the success of the government’s 10-year health plan: https://t.co/b2Ss3ocY2V
0
0
0
🧬What's the difference between PCR and antigen testing? Check out this helpful infographic on Cepheid's Insight Hub for a detailed explanation: https://t.co/NuVhgV4z0o
0
0
0
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions Read the full press release: https://t.co/y1Bw4HJDN0
cepheid.mediaroom.com
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif.,
0
2
2